TY - JOUR
T1 - Transendothelial migratory pathways of Vδ+TCRγδ+ and Vδ2+TCRγδ+ T lymphocytes from healthy donors and multiple sclerosis patients
T2 - Involvement of phosphatidylinositol 3 kinase and calcium calmodulin-dependent kinase II
AU - Poggi, Alessandro
AU - Zocchi, Maria Raffaella
AU - Carosio, Roberta
AU - Ferrero, Elisabetta
AU - Angelini, Daniela F.
AU - Galgani, Simona
AU - Caramia, Maria D.
AU - Bernardi, Giorgio
AU - Borsellino, Giovanna
AU - Battistini, Luca
PY - 2002/6/15
Y1 - 2002/6/15
N2 - We have previously reported that the Vδ2+TCRγδ+ T lymphocyte subset, expressing the NK receptor protein la (NKRP1a; CD161), is expanded in patients with relapsing-remitting multiple sclerosis and uses this molecule to migrate through endothelium. In this work, we show that Vδ1+ and Vδ2+ γδ T lymphocytes use distinct signal transduction pathways to accomplish this function. Indeed, we have found that Vδ1+ cells lack NKRP1a and selectively express the platelet endothelial cell adhesion molecule 1 (PECAM1; CD31), which drives transendothelial migration of this cell subset, at variance with Vδ2+ T cells, which are PECAM1 negative and use NKRP1a for transmigration. Interestingly, when Vδ2+ T cells were pretreated with two specific inhibitors of the calcium calmodulin-dependent kinase II KN62 and KN93, but not with the inactive compound KN92, the number of migrating cells and the rate of transmigration were significantly decreased. In turn, the phosphatidylinositol 3 kinase blockers wortmannin and LY294002 exerted a dose-dependent inhibition of Vδ1+ cell migration. Finally, NKRP1a and PECAM1 engagement led to activation of different signal transduction pathways: indeed, oligomerization of NKRP1a on Vδ2+ T cells activates calcium calmodulin-dependent kinase II, while occupancy of PECAM1 on Vδ1+ cells triggers the phosphatidylinositol 3 kinase-dependent Akt/protein kinase Ba activation. These findings suggest that subsets of γδ T lymphocytes may migrate to the site of lesion in multiple sclerosis using two different signaling pathways to extravasate.
AB - We have previously reported that the Vδ2+TCRγδ+ T lymphocyte subset, expressing the NK receptor protein la (NKRP1a; CD161), is expanded in patients with relapsing-remitting multiple sclerosis and uses this molecule to migrate through endothelium. In this work, we show that Vδ1+ and Vδ2+ γδ T lymphocytes use distinct signal transduction pathways to accomplish this function. Indeed, we have found that Vδ1+ cells lack NKRP1a and selectively express the platelet endothelial cell adhesion molecule 1 (PECAM1; CD31), which drives transendothelial migration of this cell subset, at variance with Vδ2+ T cells, which are PECAM1 negative and use NKRP1a for transmigration. Interestingly, when Vδ2+ T cells were pretreated with two specific inhibitors of the calcium calmodulin-dependent kinase II KN62 and KN93, but not with the inactive compound KN92, the number of migrating cells and the rate of transmigration were significantly decreased. In turn, the phosphatidylinositol 3 kinase blockers wortmannin and LY294002 exerted a dose-dependent inhibition of Vδ1+ cell migration. Finally, NKRP1a and PECAM1 engagement led to activation of different signal transduction pathways: indeed, oligomerization of NKRP1a on Vδ2+ T cells activates calcium calmodulin-dependent kinase II, while occupancy of PECAM1 on Vδ1+ cells triggers the phosphatidylinositol 3 kinase-dependent Akt/protein kinase Ba activation. These findings suggest that subsets of γδ T lymphocytes may migrate to the site of lesion in multiple sclerosis using two different signaling pathways to extravasate.
UR - http://www.scopus.com/inward/record.url?scp=0037097504&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037097504&partnerID=8YFLogxK
M3 - Article
C2 - 12055216
AN - SCOPUS:0037097504
VL - 168
SP - 6071
EP - 6077
JO - Journal of Immunology
JF - Journal of Immunology
SN - 0022-1767
IS - 12
ER -